Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1278587

registered interest
date	20/01/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people received (a) chemotherapy and (b) radiotherapy for the treatment of (i) breast cancer, (ii) bowel cancer, (iii) lung cancer, (iv) blood cancer and (v) prostate cancer in each of the last 12 months for which figures are available.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	140773
answer	answer is ministerial correction date of answer 27/01/2021 answer text <p>The information is not available in the format requested.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 27/01/2021 14:01:04 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1270811

registered interest
date	14/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how clinically extremely vulnerable people will be identified for the purposes of covid-19 vaccination.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	128926
answer	answer is ministerial correction date of answer 18/01/2021 answer text <p>The vaccine prioritisation is focussing on those most at risk of mortality and morbidity, beginning with care home residents and staff, people over 80 years old and frontline health and social care workers. People who are defined as clinically extremely vulnerable (CEV) are considered to be at high risk of severe illness from COVID-19. Many individuals considered as CEV are in the oldest age groups and so will be called for vaccination as part of their age cohort. However, for those that are not captured by their age group, the Joint Committee on Vaccination and Immunisation also advises that, given the level of risk seen in the CEV group as a whole, the remainder of the group should be offered vaccine alongside those 70-74 years of age. People will receive an invitation to come forward to receive their vaccination, in the form of a letter either from their general practitioner (GP) or the national booking system. This will include all the information they need, including their National Health Service number.</p><p>Anyone who is in the CEV group and for whom the vaccine is contraindicated, will instead have a consultation with their GP or another clinician responsible for their care when it would be their time to be vaccinated.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 128927 128929 question first answered 18/01/2021 12:02:08 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3960 label Biography information for Henry Smith

1270812

registered interest
date	14/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to invite clinically extremely vulnerable people for covid-19 vaccination.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	128927
answer	answer is ministerial correction date of answer 18/01/2021 answer text <p>The vaccine prioritisation is focussing on those most at risk of mortality and morbidity, beginning with care home residents and staff, people over 80 years old and frontline health and social care workers. People who are defined as clinically extremely vulnerable (CEV) are considered to be at high risk of severe illness from COVID-19. Many individuals considered as CEV are in the oldest age groups and so will be called for vaccination as part of their age cohort. However, for those that are not captured by their age group, the Joint Committee on Vaccination and Immunisation also advises that, given the level of risk seen in the CEV group as a whole, the remainder of the group should be offered vaccine alongside those 70-74 years of age. People will receive an invitation to come forward to receive their vaccination, in the form of a letter either from their general practitioner (GP) or the national booking system. This will include all the information they need, including their National Health Service number.</p><p>Anyone who is in the CEV group and for whom the vaccine is contraindicated, will instead have a consultation with their GP or another clinician responsible for their care when it would be their time to be vaccinated.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 128926 128929 question first answered 18/01/2021 12:02:08 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3960 label Biography information for Henry Smith

1270814

registered interest
date	14/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to identify clinically extremely vulnerable people who are at high risk from covid-19 but who cannot receive vaccines for clinical reasons; and what steps he will take to notify those individuals.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	128929
answer	answer is ministerial correction date of answer 18/01/2021 answer text <p>The vaccine prioritisation is focussing on those most at risk of mortality and morbidity, beginning with care home residents and staff, people over 80 years old and frontline health and social care workers. People who are defined as clinically extremely vulnerable (CEV) are considered to be at high risk of severe illness from COVID-19. Many individuals considered as CEV are in the oldest age groups and so will be called for vaccination as part of their age cohort. However, for those that are not captured by their age group, the Joint Committee on Vaccination and Immunisation also advises that, given the level of risk seen in the CEV group as a whole, the remainder of the group should be offered vaccine alongside those 70-74 years of age. People will receive an invitation to come forward to receive their vaccination, in the form of a letter either from their general practitioner (GP) or the national booking system. This will include all the information they need, including their National Health Service number.</p><p>Anyone who is in the CEV group and for whom the vaccine is contraindicated, will instead have a consultation with their GP or another clinician responsible for their care when it would be their time to be vaccinated.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 128926 128927 question first answered 18/01/2021 12:02:08 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3960 label Biography information for Henry Smith

1270815

registered interest
date	14/12/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he will take to assess the effectiveness of covid-19 vaccines in immunocompromised people post-vaccination.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	128930
answer	answer is ministerial correction date of answer 23/12/2020 answer text <p>Prior to the recent authorisation, the efficacy of COVID-19 mRNA Vaccine BNT162b2 was evaluated in two clinical studies. Both studies excluded immunocompromised subjects and therefore no data is available about use of the vaccine when used at the same time as immunosuppressant medicines or the immune response to the vaccine in those on such medications. The second trial allowed inclusion of subjects with autoimmune disorders who were not currently receiving immunosuppressants. There are no specific contraindications or warnings in the product information regarding use in individuals with autoimmune disease.</p><p>Evaluation of data for other vaccines is ongoing but will include a robust review of all quality, safety and efficacy data, including in immunocompromised subjects if they were included in clinical trials.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 23/12/2020 11:56:22 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1251465

registered interest
date	12/11/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Blood Cancer: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 June 2020 to Question 40578, how many people who are on the shielding list and defined as clinically extremely vulnerable with blood cancer are aged (a) 80 and over (b) between 75 and 79 (c) between 70 and 74 (d) between 65 and 69, (e) between 60 and 64 and (f) 59 or younger.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	114831
answer	answer is ministerial correction date of answer 27/01/2021 answer text <p>The following table shows a count of patients that are classified as being on the Shielded Patient List (SPL) in England with a blood cancer disease group by age band, as at 3 December 2020.</p><table><tbody><tr><td><p>Age Band</p></td><td><p>Patients on the SPL</p></td></tr><tr><td><p>80 years old and over</p></td><td><p>35,298</p></td></tr><tr><td><p>75-79 years old</p></td><td><p>25,773</p></td></tr><tr><td><p>70-74 years old</p></td><td><p>29,676</p></td></tr><tr><td><p>65-69 years old</p></td><td><p>22,680</p></td></tr><tr><td><p>60-64 years old</p></td><td><p>19,084</p></td></tr><tr><td><p>59 years old or younger</p></td><td><p>55,362</p></td></tr></tbody></table><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 27/01/2021 14:50:41 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1247383

registered interest
date	30/10/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether NHS staff working directly in the care and treatment of people who are immuno-compromised are being prioritised for covid-19 testing even when asymptomatic; and if he will make a statement.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	109295
answer	answer is ministerial correction date of answer 06/12/2020 answer text <p>Asymptomatic testing is currently mainly conducted for outbreak investigation and infection control - where prevalence is thought to be higher and/or where individuals are more at risk from COVID-19. This includes patients, National Health Service staff, care home staff and residents.</p><p>As capacity increases and new innovations come onstream, and as we gain new clinical and scientific evidence, we will continually review our approach to asymptomatic testing to ensure we are deploying it in the most effective way and expand our testing offer.</p><p> </p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 06/12/2020 16:05:21 answering member 4527 label Biography information for Helen Whately
tabling member	3960 label Biography information for Henry Smith

1247385

registered interest
date	30/10/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he estimates the evidence-based model to predict risk of death or hospitalisation from covid-19, which has been developed by the University of Oxford, will be in use in the NHS.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	109296
answer	answer is ministerial correction date of answer 02/12/2020 answer text <p>NHS England and NHS Improvement have been using the University of Oxford’s ‘OpenABM-Covid19’ model for several months and it is used alongside other estimates and projections of hospital admissions including those provided via the Scientific Pandemic Influenza Group on Modelling.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 02/12/2020 16:54:25 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1247386

registered interest
date	30/10/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether people who live in the same home as people who are clinically extremely vulnerable will receive a vaccine for covid-19 before the rest of the general public.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	109297
answer	answer is ministerial correction date of answer 18/11/2020 answer text <p>Whilst there is a desire for the whole United Kingdom population to be vaccinated, there may need to be an element of prioritisation based on vaccine supply, availability and evidence as data emerges from clinical trials on safety and efficacy in different cohorts of the population.</p><p>The Joint Committee on Vaccination and Immunisation (JCVI) are the independent experts who provide advice to Government on which vaccine(s) the UK should use and which groups within the population to prioritise. The JCVI and the JCVI sub-committee are currently reviewing evidence on clinical risk factors associated with serious disease and mortality from COVID-19. Following a review of the evidence, the Committee will develop advice on risk groups for any future COVID-19 vaccination programme.</p><p>The latest JCVI recommendations on the priority groups for a COVID-19 vaccine is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-25-september-2020" target="_blank">https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-25-september-2020</a></p><p>The minutes of JCVI committee meetings and statements on COVID-19 vaccination are available at the following link:</p><p><a href="https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation" target="_blank">https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation</a></p><p><strong> </strong></p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 18/11/2020 13:04:24 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith

1243940

registered interest
date	15/10/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect on patient survival rates of delayed diagnosis and screening for colorectal cancer as a result of the covid-19 outbreak.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	104093
answer	answer is ministerial correction date of answer 04/11/2020 answer text <p>The UK National Screening Committee is undertaking work to estimate the impact of delays to screening programmes, including cancer screening, caused by the COVID-19 pandemic. This work is currently in its early stages and the results will be reported as soon they are available.</p><p>NHS England and NHS Improvement is working to clear the backlog of bowel cancer screening as quickly as possible. All 64 bowel screening centres are now undertaking diagnostic colonoscopies and sending routine screening invitations. As at 5 October 2020, the number of people who have had a faecal immunochemical test-positive result and are awaiting a diagnostic test has nearly halved in comparison to those waiting in April 2020.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 04/11/2020 11:20:41 answering member 4380 label Biography information for Jo Churchill
tabling member	3960 label Biography information for Henry Smith